Agios Pharmaceuticals Inc (AGIO)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 4.31M | 5.61M | 6.71M | 7.4M | 7.1M | 8.19M | 8.62M | 8.96M |
営業利益 | -99.17M | -90.61M | -93.7M | -100.9M | -106.28M | -92.07M | -105.82M | -102.81M |
税引前収入 | 36.53M | -81.02M | -83.81M | -91.32M | -95.94M | -81.55M | -96.12M | 1B |
純利益 | 36.53M | -81.02M | -83.81M | -91.32M | -95.94M | -81.55M | -96.12M | 947.92M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -87.96M | -89.11M | -92.06M | -99.7M | -104.56M | -90.44M | -104.24M | 98.84M |
EBITDA | -97.36M | -88.82M | -91.89M | -99.27M | -104.87M | -90.72M | -104.22M | -101.47M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 69.89M | 43.01M | 94.39M | 117.91M | 203.2M | 41.41M | 14.24M | 26.82M |
営業利益 | -200.99M | -320.79M | -362.48M | -426.33M | -316.15M | -387.83M | -389.05M | -391.49M |
税引前収入 | -198.47M | -314.67M | -346.03M | -411.47M | -327.37M | 1.62B | -231.8M | -352.09M |
純利益 | -198.47M | -314.67M | -346.03M | -411.47M | -327.37M | 1.6B | -231.8M | -352.09M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -4.701 | -6.445 | -5.944 | -6.016 | -4.724 | 29.534 | -4.212 | -6.3 |
EBIT | -200.99M | -320.79M | -362.48M | -426.33M | -316.15M | 1.62B | -372.45M | -385.43M |
EBITDA | -195.28M | -314.36M | -355.31M | -418.25M | -306.17M | -378.59M | -380.48M | -384.86M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約